Literature DB >> 6771262

Undersulfated proteoglycans are secreted by cultured chondrocytes in the presence of the ionophore monensin.

K Tajiri, N Uchida, M L Tanzer.   

Abstract

The monovalent ionophore, monensin, inhibits secretion of many different proteins from a wide variety of cells. The site of blockage is at the golgi complex. We have exposed chick embryo chondrocytes in suspension culture to monensin, at concentrations ranging from 10(-8) to 10(-6) M. At the higher concentrations, between 10(-7) and 10(-6) M, monensin inhibited secretion of type II procollagen, which accumulated in the chondrocytes. At these concentrations of the ionophore, proteoglycan synthesis was inhibited, as measured by radioactive serine incorporation into core proteins and by radioactive glucosamine or SO4 incorporation into glycosaminoglycans. However, at a monensin concentration of 3 x 10(-8) M, the incorporations of serine and glucosamine were close to normal while SO4 incorporation was at 30% of control values. The ratio of glucosamine to serine in pronase-released glycosaminoglycans from culture media was unaffected by 3 x 10(-8) M monensin but the sulfate to serine ratio decreased to 29% of control values. Examination of the glycosaminoglycans by gel filtration showed a progressive increase in Kav values as sulfation decreased. Undersulfation was demonstrated by radiochromatographic analysis of the digestion products following incubation with chondroitinase ABC. The composite results show that monensin interferes with sulfation of newly synthesized proteoglycans.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6771262

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Monensin inhibits the first cellular movements in early chick embryo.

Authors:  Nikolas Zagris; Maria Panagopoulou
Journal:  Rouxs Arch Dev Biol       Date:  1991-06

2.  Monensin-induced inhibition of cell spreading in normal and dystrophic human fibroblasts.

Authors:  J Pizzey; J Witkowski; G Jones
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

3.  Unique glycoprotein-proteoglycan complex defined by monoclonal antibody on human melanoma cells.

Authors:  T F Bumol; R A Reisfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

4.  Monensin inhibits synthesis of proteoglycan, but not of hyaluronate, in chondrocytes.

Authors:  D Mitchell; T Hardingham
Journal:  Biochem J       Date:  1982-01-15       Impact factor: 3.857

5.  Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus and in vitro properties.

Authors:  J Anderson; J A Byrne; R Schreiber; S Patterson; M B Oldstone
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

6.  Immunocytochemical localization of procollagen and fibronectin in human fibroblasts: effects of the monovalent ionophore, monensin.

Authors:  P W Ledger; N Uchida; M L Tanzer
Journal:  J Cell Biol       Date:  1980-12       Impact factor: 10.539

Review 7.  Alteration of intracellular traffic by monensin; mechanism, specificity and relationship to toxicity.

Authors:  H H Mollenhauer; D J Morré; L D Rowe
Journal:  Biochim Biophys Acta       Date:  1990-05-07

8.  Differential effect of monensin on enveloped viruses that form at distinct plasma membrane domains.

Authors:  F V Alonso; R W Compans
Journal:  J Cell Biol       Date:  1981-06       Impact factor: 10.539

9.  Proteoglycan biosynthesis in chondrocytes: protein A-gold localization of proteoglycan protein core and chondroitin sulfate within Golgi subcompartments.

Authors:  A Ratcliffe; P R Fryer; T E Hardingham
Journal:  J Cell Biol       Date:  1985-12       Impact factor: 10.539

10.  Replication and morphogenesis of avian coronavirus in Vero cells and their inhibition by monensin.

Authors:  F V Alonso-Caplen; Y Matsuoka; G E Wilcox; R W Compans
Journal:  Virus Res       Date:  1984       Impact factor: 3.303

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.